Consumer

Five things for pharma marketers to know: Wednesday, November 19

Five things for pharma marketers to know: Wednesday, November 19

By

Sanofi vets Takeda, devicemaker CEO candidates; Shaq returns for IcyHot; Royalty Pharma buys royalties on Vertex's Kalydeco.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.

Bayer buys Merck OTC portfolio

Bayer buys Merck OTC portfolio

By

The $14.2-billion deal is expected to close in the second half of this year.

Medicate responsibly, urges maker of Tylenol

Medicate responsibly, urges maker of Tylenol

By

J&J's campaign picks up where the FDA left off when it alerted physicians to concerns about prescribing acetaminophen-containing drugs but deferred action relative to OTC products.

Another study about doctor-patient divide

Novo's global diabetes study finds that only 29% of polled patients were asked what they thought about prescribed regimens.

Tylenol's crisis manager Lawrence Foster dies at 88

Lawrence Foster's crisis management strategy has become the touchstone for reputation management. His advice is credited with saving Tylenol from being wiped from the marketplace, despite a deadly tampering crisis.

Mylan expands Get Schooled anaphylaxis tool box

Mylan expands Get Schooled anaphylaxis tool box

By

The EpiPen manufacturer's latest effort: an e-book that shows children making allergy-friendly swaps at a school event.

Merck's Heller on how to get more women into the C-suite

Merck's Heller on how to get more women into the C-suite

By

Bridgette Heller, Merck EVP and president of its consumer care division, adjured life-sci managers to enable women to unleash the full power of their knowledge and ideas to drive growth in the business.

Studies show cheaper drugs don't add up to greater use

By

Two studies released show that the story behind lower consumer healthspend isn't about generics improving health.

WebMD on the hunt for new business

WebMD on the hunt for new business

By

The CEO's unexpected departure is part of the health information brand's latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.

Docs haven't mellowed on DTC, snap poll suggests

Docs haven't mellowed on DTC, snap poll suggests

By

The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won't like the answers.

Duchesnay returns morning sickness drug to US market

By

The first drug for morning sickness in thirty years enters the market this month.

Business Briefs: Manhattan Research, KPMG, Scioderm and GSK

Health-seeking consumers continue social-media push; Scioderm scores FDA's "Breakthrough" designation for bullosa agent; and GSK files NDA for airway treatment.

It's Consumer's Choices as Guidelines Change

It's Consumer's Choices as Guidelines Change

Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer.

Charlie Kimball talks Novo Racing with insulin

Charlie Kimball talks Novo Racing with insulin

By

IndyCar's first licensed driver heads up a diabetes awareness campaign that focuses on community—both online and in real life.

J&J OTC sales slipped 3% in 2012 worldwide

By

CEO Alex Gorsky said OTC brands are coming back. Meanwhile, pharmaceutical sales provided ballast to the year's numbers.

Bayer lands Airborne marketer Schiff in $1.2B buy

By

Bayer HealthCare inked a deal to swallow vitamin and supplement company Schiff Nutrition International, in a transaction valued at about $1.2 billion.

Harte-Hanks launches health and wellness agency True

Harte-Hanks launches health and wellness agency True

By

Harte-Hanks, the direct marketing giant, is looking to break off a piece of the burgeoning health and wellness market with the launch of True Health + Wellness.

WebMD gives mag a celebtastic, photo-forward refresh

WebMD gives mag a celebtastic, photo-forward refresh

By

WebMD executed a cross-platform magazine redesign with a more visual and celeb-centric new look.

Pfizer bets on Rx-to-OTC Nexium switch

Pfizer bets on Rx-to-OTC Nexium switch

By

The drugmaker is paying $250 million to Nexium marketer AstraZeneca for the rights to sell an OTC version, in a deal that may signal a deepening relationship between the two firms.

Consumers getting comfortable with social media as a health resource

By

Around a third of US adults use social media as a health resource, according to a survey by PricewaterhouseCoopers - whether seeking out medical info, sharing symptoms and experiences or rating drugs, devices, doctors, hospitals and health plans.

Sites touting surgeries are one-sided, says study

By

The drug industry gets a lot of grief over its online communications to consumers, but a study has found that sites posted by doctors and hospitals and touting surgeries are often dreadful—and far less tightly regulated.

Consumers to disease: You're not the boss of me

By

A global study of consumer attitudes towards health found evidence for the "empowered consumer" hypothesis, with respondents expressing a greater sense of control over and responsibility for their health.

As GSK jettisons consumer brands, smaller marketer sees boon

As GSK jettisons consumer brands, smaller marketer sees boon

By

GlaxoSmithKline divested North American OTC drugs worth about $200 million in sales, a portfolio that seemed like a good strategic fit for buyer Prestige Brands Holdings.

Advil Congestion effort ties traffic gridlock to cold and flu misery

Advil Congestion effort ties traffic gridlock to cold and flu misery

By

Don't tell the New York Post, but Pfizer is boosting bike lanes as part of an Advil promotion.

Branded Benlysta DTC campaign ready to roll out

By

New online and print DTC advertising targeting US patients with lupus will appear "within weeks," said executives from Human Genome Sciences. Can the campaign revive blockbuster fortunes for Benlysta?

Novartis and Amazing Race host ride tandem for MS awareness

Novartis and Amazing Race host ride tandem for MS awareness

By

Amazing Race host Phil Keoghan will lead a Novartis-sponsored team of women pro cyclists on a 10-city bike tour to raise awareness of MS.

Patients prefer health media sites to user-generated content for medical info, says survey

By

Consumers continue to trust health magazines, websites and WebMD more than user-generated contribution sites like Wikipedia, Facebook or Twitter for medical information, according to a survey.

GSW launches health and wellness practice

By

InVentiv's GSW is going after the consumer health and wellness market with an offshoot, dubbed The Well @GSW, aimed at OTC brands, consumer products and retail accounts.

Havas launches "#a11y" digital practice for disabilities market

Havas launches "#a11y" digital practice for disabilities market

By

Havas Drive has launched a practice focused on developing digital products for persons with disabilities and those undergoing rehabilitative therapies.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters